GPhA appoints new VP corporate development, administration

WASHINGTON — The Generic Pharmaceutical Association announced Monday that it had appointed Anna McDermott-Vitak to be the organization’s VP corporate development and administration. McDermott-Vitak’s role will be overseeing GPhA’s membership, human resources, finance, IT and meetings. 

 

“Anna will strengthen our external engagement with current and prospective member organizations,” GPhA president and CEO Chip Davis said. “Anna’s vast experience will be valuable in efforts to enhance association operations, maximize our growth opportunities and help GPhA address the issues that matter most to stakeholders in the dynamic and rapidly growing generic drug and biosimilars markets.”

 

McDermott-Vitak, who was most recently Amgen’s executive director of global government affairs, has experience in product development, investor relations, government affairs, which she has acquired during her twenty years in biotechnology. 

 

“I’m thrilled to be part of a team that helps bring more affordable medicine to millions of patients,” McDermott-Vitak said. “At a time when health costs are under scrutiny, this industry has a consistent record of generating billions in patient and health system savings while expanding access. I look forward to growing the voice of GPhA within and beyond the Beltway while guiding the association through an exciting period of development and expansion.”